MentionFox
Home › Grants › Electronic Biosciences, Inc.
Federal R&D award · SBIR Phase I

Electronic Biosciences, Inc. SBIR Phase I award

Award R43DA063260, starting 2025-04-01. Every figure below is from the federal award record.

Department of Health and Human Services, through National Institutes of Health, awarded Electronic Biosciences, Inc. of San Diego, CA $386,452 under the SBIR program (Phase I), with work starting 2025-04-01 and running to 2027-03-31. It is one of 3 SBIR and STTR awards Electronic Biosciences, Inc. received in the last two years, $1,119,934 in all. Each figure links to the federal record.

The award

RecipientElectronic Biosciences, Inc. (San Diego, CA)
Awarding agencyDepartment of Health and Human Services
Awarding officeNational Institutes of Health
PhasePhase I
Amount obligated$386,452
Period of performance starts2025-04-01
Period of performance ends2027-03-31
Award numberR43DA063260 (grant, CFDA 93.279)
Assistance listing93.279, Drug Use and Addiction Research Programs
Signed2025-03-19
Recipient registry id (UEI)FLHHE89XH2H5

Want the whole picture on Electronic Biosciences, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Electronic Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Electronic Biosciences, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    3 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on Target: the verdict, 16 sections, 39 cited sources, dated 2026-09-28A real finished report, first screen. Opens in a new tab.

What it is for

Rapid fingerstick diagnostics for opioid and stimulant use disorders - project summary opioid and stimulant use disorders (oud/stud) represent an escalating public health crisis in the united states, with more than 107,0

Funding actions on this award

DateActionModificationAmount
2026-01-06Revision000$0
2025-03-19New000$386,452
Rapid fingerstick diagnostics for opioid and stimulant use disorders - project summary opioid and stimulant use disorders (oud/stud) represent an escalating public health crisis in the united states, with more than 107,000 overdose deaths reported in 2022, driven predominantly by synthetic opioids (e.g., fentanyl) and increasing use of stimulants like methamphetamine and cocaine. Despite available treatments, <10% of individuals with substance use disorders receive the care they need. Existing diagnostic methods, which rely on urine and blood tests, are hindered by logistical constraints (specialized facilities, multiple sample collections, laboratory processing, and delayed results). Moreover, they do not simultaneously assess for the presence of all opioids, stimulants, and their metabolites, nor do they screen for related critical health indicators such as pregnancy, cardiac injury, cardiovascular stress, inflammation, bacterial infections, clot formation, and neuronal and brain injury. These barriers impede timely intervention and effective monitoring of patients, particularly in underserved and remote areas. The development of an innovative, rapid, and comprehensive diagnostic tool is urgently needed to bridge this gap. Such a tool would enable early detection and continuous monitoring of oud/stud, facilitating timely medical interventions that could significantly reduce t ...

From the federal award record.

Other SBIR and STTR awards to Electronic Biosciences, Inc.

StartsAgencyProgramAmountProject
2025-06-06Department of Health and Human ServicesSBIR Phase I$383,482Spinseq - project summary RNA sequencing technologies are crucial for understanding gene e (record)
2025-06-01Department of Health and Human ServicesSTTR Phase I$350,000High-resolution pseudouridine and M6A sequencing through advanced nanopore adduct analysis (record)
Want the whole picture on Electronic Biosciences, Inc.?

Who runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.

Order Full Report on Electronic Biosciences, Inc.
Not ready to order?

Look up Electronic Biosciences, Inc. and see what is on record before you decide.

Get the free Snapshot

Where this comes from

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.

Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.

Cite this page

Permanent URL: https://mentionfox.com/grants/electronic-biosciences-r43da063260
Last updated 2026-09-30
Primary record: Federal award record
Electronic Biosciences, Inc.: $386,452 SBIR Phase I award from HHS (2025). MentionFox, 2026-09-30. https://mentionfox.com/grants/electronic-biosciences-r43da063260